Inheritance + Innovation + Development: The "Co-development" Path of Hakka Medicine and Traditional Chinese Medicine
HONG KONG, Dec. 9, 2025 /PRNewswire/ -- From November 23 to 25, the Seventh World Hakka Entrepreneurs Convention was held in Meizhou, Guangdong. The conference, with the theme of "Gather Global Hakka Entrepreneurs • Facilitate High-Quality...
Innovent Announces PECONDLE® (Picankibart Injection) Phase 3 Study (CLEAR-2) Meets Endpoints, Delivering Superior Long-Term Management Solution for Moderate-to-Severe Psoriasis
SAN FRANCISCO and SUZHOU, China, Dec. 9, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Kia PV5 Cargo Achieves Maximum Five-Star Rating in 2025 Euro NCAP Commercial Van Safety Assessment
Kia PV5 Cargo earns the top five-star rating in the 2025 Euro NCAP Commercial Van Safety assessment Strong performance across key categories, including Occupant Protection, Safety Assist/Crash Avoidance and Post-Crash Safety Standard ADAS...
ADFW Opens with Spotlight on Abu Dhabi's Global Ambition and Major Humanitarian Pledge
ABU DHABI, UAE, Dec. 9, 2025 /PRNewswire/ -- Abu Dhabi Finance Week (ADFW) 2025 opened today with some of the world's most influential financial and business leaders engaging in critical discourse around the capital's evolving economic landscape and...
From a Simple Idea to a Global Standard: EV Blocks Founder Wins Global Entrepreneur of the Year 2025
What started as a frustration on site has become a global product. PETERBOROUGH, England, Dec. 9, 2025 /PRNewswire/ -- EV Blocks is proud to share that founder Trevor Palmer has been named Global Entrepreneur of the Year 2025 at The Allica Bank...
With Child Deaths Projected to Rise for the First Time in a Century, Gates Foundation and Mohamed Bin Zayed Foundation for Humanity Urge Action as World Faces Critical Turning Point
At Goalkeepers Abu Dhabi, global leaders outline a path to improve and save the lives of millions of children through lifesaving innovation and renewed investment Partners announce $1.9 billion to advance polio eradication Event held in partnership...
EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide
PROVIDENCE, R.I., Dec. 9, 2025 /PRNewswire/ -- EpiVax, Inc., with U.S. Food and Drug Administration (FDA) and CUBRC, Inc. (Buffalo, NY) scientist collaborators, announces the publication of a study titled "Immunogenicity Risk Assessment of...
Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as well as in both metastatic and early stage breast cancer. FLORENCE, Italy and NEW YORK,...